Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
After adjustment for confounding variables, risk of endometrial cancer was increased almost fourfold with tamoxifen treatment.
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Factors other than access may affect differences in survival, according to researchers.
The disparity is due to the greater prevalence of fibroids and nonendometrioid histologic type in Black women, according to researchers.
Data showed increases in endometrial cancer and obesity in women younger than 40.
Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives.
Researchers identified factors for increased risk of clinically significant fatigue among women who underwent surgery for gynecologic cancers.
The trajectory of follow-up care for women undergoing a failed endometrial biopsy has been largely unexplored.